DE69332582D1 - Rapamycinderivate - Google Patents

Rapamycinderivate

Info

Publication number
DE69332582D1
DE69332582D1 DE69332582T DE69332582T DE69332582D1 DE 69332582 D1 DE69332582 D1 DE 69332582D1 DE 69332582 T DE69332582 T DE 69332582T DE 69332582 T DE69332582 T DE 69332582T DE 69332582 D1 DE69332582 D1 DE 69332582D1
Authority
DE
Germany
Prior art keywords
rapamycin derivatives
rapamycin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69332582T
Other languages
English (en)
Other versions
DE69332582T2 (de
Inventor
Dennis Alan Holt
Juan Ignacio Luengo
Rozamus, Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of DE69332582D1 publication Critical patent/DE69332582D1/de
Application granted granted Critical
Publication of DE69332582T2 publication Critical patent/DE69332582T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69332582T 1992-07-17 1993-07-16 Rapamycinderivate Expired - Fee Related DE69332582T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91514792A 1992-07-17 1992-07-17
PCT/US1993/006680 WO1994002137A1 (en) 1992-07-17 1993-07-16 Rapamycin derivatives

Publications (2)

Publication Number Publication Date
DE69332582D1 true DE69332582D1 (de) 2003-01-30
DE69332582T2 DE69332582T2 (de) 2003-11-20

Family

ID=25435302

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69332582T Expired - Fee Related DE69332582T2 (de) 1992-07-17 1993-07-16 Rapamycinderivate

Country Status (9)

Country Link
US (1) US5661156A (de)
EP (1) EP0650357B1 (de)
JP (1) JPH07509248A (de)
CN (1) CN1087912A (de)
AU (1) AU4680193A (de)
DE (1) DE69332582T2 (de)
MX (1) MX9304361A (de)
WO (1) WO1994002137A1 (de)
ZA (1) ZA935110B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA935111B (en) * 1992-07-17 1994-02-04 Smithkline Beecham Corp Rapamycin derivatives
USRE37421E1 (en) 1993-07-16 2001-10-23 Smithkline Beecham Corporation Rapamycin derivatives
US5527907A (en) * 1993-11-19 1996-06-18 Abbott Laboratories Macrolide immunomodulators
EP0729471A1 (de) * 1993-11-19 1996-09-04 Abbott Laboratories Semisynthetische rapamycin analoge mit immunomodulatorischer wirkung
US5525610A (en) * 1994-03-31 1996-06-11 American Home Products Corporation 42-Epi-rapamycin and pharmaceutical compositions thereof
US5563145A (en) * 1994-12-07 1996-10-08 American Home Products Corporation Rapamycin 42-oximes and hydroxylamines
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
US6258823B1 (en) * 1996-07-12 2001-07-10 Ariad Pharmaceuticals, Inc. Materials and method for treating or preventing pathogenic fungal infection
US5939750A (en) * 1998-01-21 1999-08-17 Advanced Micro Devices Use of implanted ions to reduce oxide-nitride-oxide (ONO) etch residue and polystringers
AU783158B2 (en) 1999-08-24 2005-09-29 Ariad Pharmaceuticals, Inc. 28-epirapalogs
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
WO2004060283A2 (en) 2002-12-16 2004-07-22 Nitromed, Inc. Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
WO2005010010A1 (en) * 2003-07-16 2005-02-03 Wyeth Cci-779 isomer c
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
US8021849B2 (en) * 2004-11-05 2011-09-20 Siemens Healthcare Diagnostics Inc. Methods and kits for the determination of sirolimus in a sample
US7189582B2 (en) * 2005-04-27 2007-03-13 Dade Behring Inc. Compositions and methods for detection of sirolimus
CA2711765A1 (en) 2008-01-11 2009-07-16 Massachusetts Eye & Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
DE102012018013B4 (de) 2012-09-12 2014-09-18 X-Fab Semiconductor Foundries Ag Spiralförmige, integrierbare Spulen mit zentrischen Anschlüssen in planarer grabenisolierter Siliziumhalbleitertechnologie
EP3008192B1 (de) 2013-06-11 2019-07-17 Takara Bio USA, Inc. Proteinangereicherte mikrovesikel und verfahren zur herstellung und verwendung davon
CN103739616B (zh) * 2013-12-27 2015-12-30 福建省微生物研究所 含噻唑基雷帕霉素类衍生物及其应用
HUP1400075A2 (hu) 2014-02-14 2015-08-28 Druggability Technologies Ip Holdco Jersey Ltd Sirolimus és származékainak komplexei, elõállítása és gyógyszerészeti kompozíciói

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023263A (en) * 1990-08-09 1991-06-11 American Home Products Corporation 42-oxorapamycin
US5130307A (en) * 1990-09-28 1992-07-14 American Home Products Corporation Aminoesters of rapamycin
GB9125660D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Novel compound
JP3140228B2 (ja) * 1992-02-17 2001-03-05 ファイザー製薬株式会社 新規な大環状ラクトンおよびその生産菌
US5284877A (en) * 1992-06-12 1994-02-08 Merck & Co., Inc. Alkyl and alkenyl macrolides having immunosuppressive activity
ZA935111B (en) * 1992-07-17 1994-02-04 Smithkline Beecham Corp Rapamycin derivatives
GB9221220D0 (en) * 1992-10-09 1992-11-25 Sandoz Ag Organic componds

Also Published As

Publication number Publication date
EP0650357A4 (de) 1995-06-14
ZA935110B (en) 1994-02-04
JPH07509248A (ja) 1995-10-12
AU4680193A (en) 1994-02-14
DE69332582T2 (de) 2003-11-20
CN1087912A (zh) 1994-06-15
WO1994002137A1 (en) 1994-02-03
EP0650357A1 (de) 1995-05-03
MX9304361A (es) 1994-04-29
US5661156A (en) 1997-08-26
EP0650357B1 (de) 2002-12-18

Similar Documents

Publication Publication Date Title
DE69332540D1 (de) Rapamycinderivate
DE69332484D1 (de) Rapamycinderivate
ATA75293A (de) Indolderivate
FI921328A (fi) Silyletrar av rapamycin
ATE228135T1 (de) Rapamycinderivate
FI931203A0 (fi) Karboxylsyraestrar av rapamycin
NO953406D0 (no) Pyrrolo-pyridinderivater
DE69208877D1 (de) Chinuclidinderivate
DE69332582T2 (de) Rapamycinderivate
DE69330497T2 (de) Chinazolin-derivate
DE59308714D1 (de) Cyclobutan-benzol-derivate
FI955164A0 (fi) Heterosykliset johdannaiset
DE69314072T2 (de) Cephalosporin-Derivat
FI950486A (fi) Amidijohdannaiset
NO952288D0 (no) Benzazepinon-derivater
DE69313890T2 (de) 5-Aminoflavon-Derivate
MX9206710A (es) Derivados de piridinol
DE59407726D1 (de) 3-Aryl-4-hydroxy-3-dihydrofuranon-Derivate
BR9104543A (pt) Derivados de triazolpiridazina
DE69211197D1 (de) 1-Hydroxyvitamin D-Derivate
LV10955A (lv) Benzopirana atvasinajumi
DE69301681D1 (de) Oximderivate
NO932638D0 (no) 21-klor-pregnanderivat
DE59309038D1 (de) Chlorthiazolderivate
DE69400388D1 (de) Cyclohexendiolderivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee